| Literature DB >> 25750712 |
Ji Hyoun Kang1, Tereza Manousaki2, Paolo Franchini3, Susanne Kneitz4, Manfred Schartl5, Axel Meyer1.
Abstract
Swords are exaggerated male ornaments of swordtail fishes that have been of great interest to evolutionary biologists ever since Darwin described them in the Descent of Man (1871). They are a novel sexually selected trait derived from modified ventral caudal fin rays and are only found in the genus Xiphophorus. Another phylogenetically more widespread and older male trait is the gonopodium, an intromittent organ found in all poeciliid fishes, that is derived from a modified anal fin. Despite many evolutionary and behavioral studies on both traits, little is known so far about the molecular mechanisms underlying their development. By investigating transcriptomic changes (utilizing a RNA-Seq approach) in response to testosterone treatment in the swordtail fish, Xiphophorus hellerii, we aimed to better understand the architecture of the gene regulatory networks underpinning the development of these two evolutionary novelties. Large numbers of genes with tissue-specific expression patterns were identified. Among the "sword genes" those involved in embryonic organ development, sexual character development and coloration were highly expressed, while in the gonopodium rather more morphogenesis-related genes were found. Interestingly, many genes and genetic pathways are shared between both developing novel traits derived from median fins: the sword and the gonopodium. Our analyses show that a larger set of gene networks was co-opted during the development and evolution of the "older" gonopodium than in the "younger," and morphologically less complex trait, the sword. We provide a catalog of candidate genes for future efforts to dissect the development of those sexually selected exaggerated male traits in swordtails.Entities:
Keywords: Co-option; RNA-Seq; Xiphophorus; gonopodium; key innovation; male-specific traits; swordtails
Year: 2015 PMID: 25750712 PMCID: PMC4338968 DOI: 10.1002/ece3.1390
Source DB: PubMed Journal: Ecol Evol ISSN: 2045-7758 Impact factor: 2.912
Figure 1Anal and caudal fins in the control and treated fish at day 0 and day 5 (A) and details of fin rays in the developing sword and gonopodium (B). (A) In the control fish, no difference between anal fin (CG) and ventral caudal fin (CV) was observed at day 0 and day 5 (scale bar = 1 mm). In testosterone-treated fish, initiation of the transformation into a gonopodium (TG) and sword (TV) was apparent at day 5. (B) The gonopodium developed from rays 3, 4, and 5 in anal fin, and the sword developed from V7 to V10 (ventral). Tissues from dorsal rays (D7–D10) and middle rays (V1, V2, D1 and D2) were used for RNA sequencing. *T stands for treated, C for nontreated (control), V for ventral caudal rays (sword), M for middle caudal rays, D for dorsal caudal rays.
Summary statistics of Illumina sequencing. Percentage of the raw reads in each tissue is shown in parentheses
| Treated | Nontreated control | |||||
|---|---|---|---|---|---|---|
| Sword (TV) | Caudal middle (TM) | Caudal dorsal (TD) | Gonopodium (TG) | Sword (CV) | Gonopodium (CG) | |
| Raw reads | 47,457,964 | 46,049,838 | 45,121,568 | 42,942,650 | 41,862,944 | 48,853,452 |
| Filtered reads | 35,055,836 (73.87%) | 33,711,045 (73.21%) | 33,413,285 (74.05%) | 31,841,652 (74.15%) | 30,884,763 (73.78%) | 36,241,671 (74.18%) |
| Uniquely mapped reads | 32,917,816 (69.36%) | 31,540,697 (68.49%) | 31,244,476 (69.25%) | 29,898,472 (69.62%) | 28,875,936 (68.98%) | 33,820,878 (69.23%) |
| Unmapped reads | 2,138,020 (4.51%) | 2,170,348 (4.71%) | 2,168,809 (4.81%) | 1,943,180 (4.53%) | 2,008,827 (4.80%) | 2,420,793 (4.96%) |
Figure 2Venn diagram showing codifferentially expressed genes among different pairwise comparisons for sword and gonopodium. Numbers indicate the upregulated genes and those in parentheses the downregulated genes, respectively. TV stands for treated ventral ray (sword), TD for treated dorsal ray, TM for treated middle ray, TG for treated anal fin ray (gonopodium), CV for nontreated ventral ray in control fish, and CG for nontreated anal fin ray in control fish. *T stands for treated, C for nontreated (control), V for ventral caudal rays (sword), M for middle caudal rays, D for dorsal caudal rays, G for gonopodium (anal fin rays).
DEGs found between tissues and treated or nontreated individuals
| TV | TG | TD | |
|---|---|---|---|
| TM | 190 | 3070 | 0 |
| TV | – | 1485 | 86 |
| TG | – | – | 2366 |
| CG | – | 5433 | – |
| CV | 1784 | – | – |
T stands for treated, C for nontreated (control), V for ventral caudal ray (sword), M for middle caudal ray, D for dorsal caudal ray.
Sword-specific DEGs from the limited gene set (TV and CV, TV and TD, TV and TM) between tissues and treatments
| ID | Gene name | Ensembl Gene id | Ensembl Gene description |
|---|---|---|---|
| Up-regulated in developing sword | |||
| CUFF.36200.1 | AGTR1 | ENSXMAG00000020155 | Angiotensin II receptor, type 1 [Source:HGNC Symbol;Acc:336] |
| CUFF.22492.1 | ANGPTL5 | ENSXMAG00000010840 | Angiopoietin-like 5 [Source:HGNC Symbol;Acc:19705] |
| CUFF.15255.1 | ANO5 (1 of 2) | ENSXMAG00000007021 | Anoctamin 5 [Source:HGNC Symbol;Acc:27337] |
| CUFF.1503.1 | ASIP | ENSXMAG00000012156 | Agouti signaling protein [Source:HGNC Symbol;Acc:745] |
| CUFF.38557.1 | BCAN (2 of 2) | ENSXMAG00000015085 | Brevican [Source:HGNC Symbol;Acc:23059] |
| CUFF.11483.1 | CKAP4 | ENSXMAG00000001319 | Cytoskeleton-associated protein 4 [Source:HGNC Symbol;Acc:16991] |
| CUFF.35437.1 | COL10A1 (2 of 2) | ENSXMAG00000020162 | Collagen, type X, alpha 1 [Source:HGNC Symbol;Acc:2185] |
| CUFF.40385.1 | DSTN | ENSXMAG00000006139 | Destrin (actin depolymerizing factor) [Source:HGNC Symbol;Acc:15750] |
| CUFF.24718.1 | ECEL1 (1 of 2) | ENSXMAG00000002319 | Endothelin converting enzyme-like 1 [Source:HGNC Symbol;Acc:3147] |
| CUFF.37038.1 | FKBP9 | ENSXMAG00000003160 | FK506 binding protein 9, 63 kDa [Source:HGNC Symbol;Acc:3725] |
| CUFF.7252.1 | GFRA1 (1 of 2) | ENSXMAG00000014650 | GDNF family receptor alpha 1 [Source:HGNC Symbol;Acc:4243] |
| CUFF.22162.1 | GJA1 | ENSXMAG00000005269 | Gap junction protein, alpha 1, 43 kDa [Source:HGNC Symbol;Acc:4274] |
| CUFF.12280.1 | INHBB (1 of 2) | ENSXMAG00000006435 | Inhibin, beta B [Source:HGNC Symbol;Acc:6067] |
| CUFF.12283.1 | INHBB (1 of 2) | ENSXMAG00000006435 | Inhibin, beta B [Source:HGNC Symbol;Acc:6067] |
| CUFF.27942.1 | KCNH8 | ENSXMAG00000000864 | Potassium voltage-gated channel, subfamily H (eag-related), member 8 [Source:HGNC Symbol;Acc:18864] |
| CUFF.27947.1 | KCNH8 | ENSXMAG00000000864 | Potassium voltage-gated channel, subfamily H (eag-related), member 8 [Source:HGNC Symbol;Acc:18864] |
| CUFF.25856.1 | LURAP1 (1 of 2) | ENSXMAG00000002255 | Leucine rich adaptor protein 1 [Source:HGNC Symbol;Acc:32327] |
| CUFF.17142.1 | MMP20 | ENSXMAG00000001558 | Matrixmetallopeptidase 20 [Source:HGNC Symbol;Acc:7167] |
| CUFF.26478.1 | PANX3 | ENSXMAG00000006184 | Pannexin 3 [Source:HGNC Symbol;Acc:20573] |
| CUFF.33889.1 | PAX9 | ENSXMAG00000015762 | Paired box 9 [Source:HGNC Symbol;Acc:8623] |
| CUFF.15331.1 | PDIA4 | ENSXMAG00000018874 | Protein disulfide isomerase family A, member 4 [Source:HGNC Symbol;Acc:30167] |
| CUFF.25172.1 | PMEL (1 of 2) | ENSXMAG00000003314 | Premelanosome protein [Source:HGNC Symbol;Acc:10880] |
| CUFF.15589.1 | PPIC | ENSXMAG00000015311 | Peptidylprolylisomerase C (cyclophilin C) [Source:HGNC Symbol;Acc:9256] |
| CUFF.25279.1 | RCN1 | ENSXMAG00000014239 | Reticulocalbin 1, EF-hand calcium binding domain [Source:HGNC Symbol;Acc:9934] |
| CUFF.11860.1 | RCN3 | ENSXMAG00000002579 | Reticulocalbin 3, EF-hand calcium binding domain [Source:HGNC Symbol;Acc:21145] |
| CUFF.25595.1 | SLC13A5 (1 of 2) | ENSXMAG00000004065 | Solute carrier family 13 (sodium-dependent citrate transporter), member 5 [Source:HGNC Symbol;Acc:23089] |
| CUFF.5285.1 | STAC2 (2 of 2) | ENSXMAG00000002187 | SH3 and cysteine rich domain 2 [Source:HGNC Symbol;Acc:23990] |
| CUFF.26167.1 | TBX3 | ENSXMAG00000005372 | T-box 3 [Source:HGNC Symbol;Acc:11602] |
| CUFF.36189.1 | TENC1 (2 of 2) | ENSXMAG00000018693 | Tensin like C1 domain containing phosphatase (tensin 2) [Source:HGNC Symbol;Acc:19737] |
| CUFF.29119.1 | TNC (1 of 2) | ENSXMAG00000004876 | Tenascin C [Source:HGNC Symbol;Acc:5318] |
| CUFF.28413.1 | TNC (2 of 2) | ENSXMAG00000018617 | Tenascin C [Source:HGNC Symbol;Acc:5318] |
| CUFF.28417.1 | TNC (2 of 2) | ENSXMAG00000018617 | Tenascin C [Source:HGNC Symbol;Acc:5318] |
| CUFF.23730.1 | TRPC6 (1 of 2) | ENSXMAG00000010842 | Transient receptor potential cation channel, subfamily C, member 6 [Source:HGNC Symbol;Acc:12338] |
| CUFF.26841.1 | TYR (1 of 2) | ENSXMAG00000011209 | Tyrosinase [Source:HGNC Symbol;Acc:12442] |
| CUFF.25560.1 | TYRP1 (2 of 2) | ENSXMAG00000004910 | Tyrosinase-related protein 1 [Source:HGNC Symbol;Acc:12450] |
| CUFF.4663.1 | XDH | ENSXMAG00000003461 | Xanthine dehydrogenase [Source:HGNC Symbol;Acc:12805] |
| CUFF.11637.1 | #N/A | ENSXMAG00000005039 | Fibulin-7 isoform 1 |
| CUFF.12274.1 | #N/A | #N/A | #N/A |
| CUFF.17007.1 | #N/A | ENSXMAG00000018184 | A fish specific (TGD) ortholog of hedgehog interacting protein like 1 |
| CUFF.22535.1 | #N/A | ENSXMAG00000011006 | Neurexin 2a |
| CUFF.23770.1 | #N/A | #N/A | NILT2 leucocyte receptor |
| CUFF.31467.1 | #N/A | ENSXMAG00000015953 | Tubulin alpha |
| CUFF.31478.1 | #N/A | ENSXMAG00000015953 | Tubulin alpha-1a chain |
| CUFF.33581.1 | #N/A | ENSXMAG00000003979 | OX-2 membrane glycol |
| CUFF.4179.1 | #N/A | #N/A | GDNF family receptor alpha-1-like |
| CUFF.7419.1 | #N/A | ENSXMAG00000000509 | Connexin |
| CUFF.8191.1 | #N/A | ENSXMAG00000006973 | Spondin-1 precursor |
| CUFF.8192.1 | #N/A | ENSXMAG00000006973 | Spondin-1 precursor |
| Down-regulated in developing sword | |||
| CUFF.35587.1 | #N/A | #N/A | Pro-neuregulin- membrane-bound isoform |
| CUFF.12776.1 | #N/A | #N/A | #N/A |
Figure 3Sword-specific gene expression. Heatmap of the limited gene set for sword displaying significantly differential expression between treated dorsal (TD) and treated ventral (TV, sword) rays. Color coding represents normalized expression data (variance stabilization transformed data implemented in DESeq). *T stands for treated, V for ventral caudal ray (sword), D for dorsal caudal ray. One locus with extreme values was excluded (COL10A1: CUFF. 35437.1).